Friday, May 25, 2018 10:23:28 PM
WestMountain Company (WASM) reverse merger with CytoBioscience, Inc.
https://backend.otcmarkets.com/otcapi/company/sec-filings/12644875/content/html
CytoBioscience, Inc. website: http://cytobioscience.com/
Latest 10-Q (the big reveal of assets and revenue) is late. https://backend.otcmarkets.com/otcapi/company/sec-filings/12760401/content/html
Which turns out to be a chance for others to get in before the market.
The base CytoPatch unit sells for $175,000, and CytoBioScience also sells microchips, buffers, solutions, cells, and specific types of shipping containers to researchers on a recurring basis, Garvin says. CytoBioscience, which changed its name last year, was founded in Germany and moved to San Antonio in 2015. Regulatory filings show CytoBioScience had raised about $15.8 million as of August 2016.
https://www.xconomy.com/texas/2017/08/01/cytobioscience-plans-merger-with-publicly-traded-skyline-medical/
They just did a $1.5 million offering so they're flush with cash now. ($1.53 million equity round of funding)
https://www.xconomy.com/texas/2018/03/19/cytobioscience-raises-1-5m-for-intended-merger-document-says/
From the 8K - "Each of these revenue-generating segments; instruments, consumables and contract research, is a leader in its technology and in its capacity. Having undergone years of testing, starting, restarting, and honing its development into the cutting edge it is today, the Company is experiencing accelerating revenue growth and is well-positioned to reach its potential."
Share structure:
Authorized Shares 50,000,000
Outstanding Shares 11,017,402
Shares have to be issued for the merger but they're all restricted for up to 2 years per lock-up agreement.
After merger is finalized:
A/S 100,000,000
O/S 54,382,961
Back in Aug 1, 2017 CytoBioscience came close to merging with Skyline Medical now Precision Therapeutics Inc. NASDAQ (AIPT)
They bragged that CytoBioscience had a current backlog of $6 million in orders and anticipated contract research work.
http://investors.skylinemedical.com/index.php/news-releases/news-release-details/skyline-medical-signs-binding-letter-intent-merger-transaction
CytoBioscience's latest acquisition: SolubleBioScience f.k.a. Soluble Therapeutics https://solublebioscience.com/
CytoBioscience, Inc. has purchased Birmingham, Alabama-based Soluble Therapeutics and will move the company’s operations to its San Antonio location.
Details of the multi-million dollar purchase price were not disclosed.
https://solublebioscience.com/former-german-firm-bringing-more-biotech-business-to-san-antonio/
https://www.businesswire.com/news/home/20161220005098/en/Soluble-Therapeutics-Acquired-CytoBioscience
CytoBioScience has 4 locations:
New Orleans, LA
Birmingham, AL
Cologne, Germany
Einhoven, The Netherlands
WestMountain Company (WASM) reverse merger with CytoBioscience, Inc.
https://backend.otcmarkets.com/otcapi/company/sec-filings/12644875/content/html
CytoBioscience, Inc. website: http://cytobioscience.com/
Latest 10-Q (the big reveal of assets and revenue) is late. https://backend.otcmarkets.com/otcapi/company/sec-filings/12760401/content/html
Which turns out to be a chance for others to get in before the market.
The base CytoPatch unit sells for $175,000, and CytoBioScience also sells microchips, buffers, solutions, cells, and specific types of shipping containers to researchers on a recurring basis, Garvin says. CytoBioscience, which changed its name last year, was founded in Germany and moved to San Antonio in 2015. Regulatory filings show CytoBioScience had raised about $15.8 million as of August 2016.
https://www.xconomy.com/texas/2017/08/01/cytobioscience-plans-merger-with-publicly-traded-skyline-medical/
They just did a $1.5 million offering so they're flush with cash now. ($1.53 million equity round of funding)
https://www.xconomy.com/texas/2018/03/19/cytobioscience-raises-1-5m-for-intended-merger-document-says/
From the 8K - "Each of these revenue-generating segments; instruments, consumables and contract research, is a leader in its technology and in its capacity. Having undergone years of testing, starting, restarting, and honing its development into the cutting edge it is today, the Company is experiencing accelerating revenue growth and is well-positioned to reach its potential."
Share structure:
Authorized Shares 50,000,000
Outstanding Shares 11,017,402
Shares have to be issued for the merger but they're all restricted for up to 2 years per lock-up agreement.
After merger is finalized:
A/S 100,000,000
O/S 54,382,961
Back in Aug 1, 2017 CytoBioscience came close to merging with Skyline Medical now Precision Therapeutics Inc. NASDAQ (AIPT)
They bragged that CytoBioscience had a current backlog of $6 million in orders and anticipated contract research work.
http://investors.skylinemedical.com/index.php/news-releases/news-release-details/skyline-medical-signs-binding-letter-intent-merger-transaction
CytoBioscience's latest acquisition: SolubleBioScience f.k.a. Soluble Therapeutics https://solublebioscience.com/
CytoBioscience, Inc. has purchased Birmingham, Alabama-based Soluble Therapeutics and will move the company’s operations to its San Antonio location.
Details of the multi-million dollar purchase price were not disclosed.
https://solublebioscience.com/former-german-firm-bringing-more-biotech-business-to-san-antonio/
https://www.businesswire.com/news/home/20161220005098/en/Soluble-Therapeutics-Acquired-CytoBioscience
CytoBioScience has 4 locations:
New Orleans, LA
Birmingham, AL
Cologne, Germany
Einhoven, The Netherlands
I hope everyone has an enjoyable Memorial Day weekend. Stay safe.
https://backend.otcmarkets.com/otcapi/company/sec-filings/12644875/content/html
CytoBioscience, Inc. website: http://cytobioscience.com/
Latest 10-Q (the big reveal of assets and revenue) is late. https://backend.otcmarkets.com/otcapi/company/sec-filings/12760401/content/html
Which turns out to be a chance for others to get in before the market.
The base CytoPatch unit sells for $175,000, and CytoBioScience also sells microchips, buffers, solutions, cells, and specific types of shipping containers to researchers on a recurring basis, Garvin says. CytoBioscience, which changed its name last year, was founded in Germany and moved to San Antonio in 2015. Regulatory filings show CytoBioScience had raised about $15.8 million as of August 2016.
https://www.xconomy.com/texas/2017/08/01/cytobioscience-plans-merger-with-publicly-traded-skyline-medical/
They just did a $1.5 million offering so they're flush with cash now. ($1.53 million equity round of funding)
https://www.xconomy.com/texas/2018/03/19/cytobioscience-raises-1-5m-for-intended-merger-document-says/
From the 8K - "Each of these revenue-generating segments; instruments, consumables and contract research, is a leader in its technology and in its capacity. Having undergone years of testing, starting, restarting, and honing its development into the cutting edge it is today, the Company is experiencing accelerating revenue growth and is well-positioned to reach its potential."
Share structure:
Authorized Shares 50,000,000
Outstanding Shares 11,017,402
Shares have to be issued for the merger but they're all restricted for up to 2 years per lock-up agreement.
After merger is finalized:
A/S 100,000,000
O/S 54,382,961
Back in Aug 1, 2017 CytoBioscience came close to merging with Skyline Medical now Precision Therapeutics Inc. NASDAQ (AIPT)
They bragged that CytoBioscience had a current backlog of $6 million in orders and anticipated contract research work.
http://investors.skylinemedical.com/index.php/news-releases/news-release-details/skyline-medical-signs-binding-letter-intent-merger-transaction
CytoBioscience's latest acquisition: SolubleBioScience f.k.a. Soluble Therapeutics https://solublebioscience.com/
CytoBioscience, Inc. has purchased Birmingham, Alabama-based Soluble Therapeutics and will move the company’s operations to its San Antonio location.
Details of the multi-million dollar purchase price were not disclosed.
https://solublebioscience.com/former-german-firm-bringing-more-biotech-business-to-san-antonio/
https://www.businesswire.com/news/home/20161220005098/en/Soluble-Therapeutics-Acquired-CytoBioscience
CytoBioScience has 4 locations:
New Orleans, LA
Birmingham, AL
Cologne, Germany
Einhoven, The Netherlands
WestMountain Company (WASM) reverse merger with CytoBioscience, Inc.
https://backend.otcmarkets.com/otcapi/company/sec-filings/12644875/content/html
CytoBioscience, Inc. website: http://cytobioscience.com/
Latest 10-Q (the big reveal of assets and revenue) is late. https://backend.otcmarkets.com/otcapi/company/sec-filings/12760401/content/html
Which turns out to be a chance for others to get in before the market.
The base CytoPatch unit sells for $175,000, and CytoBioScience also sells microchips, buffers, solutions, cells, and specific types of shipping containers to researchers on a recurring basis, Garvin says. CytoBioscience, which changed its name last year, was founded in Germany and moved to San Antonio in 2015. Regulatory filings show CytoBioScience had raised about $15.8 million as of August 2016.
https://www.xconomy.com/texas/2017/08/01/cytobioscience-plans-merger-with-publicly-traded-skyline-medical/
They just did a $1.5 million offering so they're flush with cash now. ($1.53 million equity round of funding)
https://www.xconomy.com/texas/2018/03/19/cytobioscience-raises-1-5m-for-intended-merger-document-says/
From the 8K - "Each of these revenue-generating segments; instruments, consumables and contract research, is a leader in its technology and in its capacity. Having undergone years of testing, starting, restarting, and honing its development into the cutting edge it is today, the Company is experiencing accelerating revenue growth and is well-positioned to reach its potential."
Share structure:
Authorized Shares 50,000,000
Outstanding Shares 11,017,402
Shares have to be issued for the merger but they're all restricted for up to 2 years per lock-up agreement.
After merger is finalized:
A/S 100,000,000
O/S 54,382,961
Back in Aug 1, 2017 CytoBioscience came close to merging with Skyline Medical now Precision Therapeutics Inc. NASDAQ (AIPT)
They bragged that CytoBioscience had a current backlog of $6 million in orders and anticipated contract research work.
http://investors.skylinemedical.com/index.php/news-releases/news-release-details/skyline-medical-signs-binding-letter-intent-merger-transaction
CytoBioscience's latest acquisition: SolubleBioScience f.k.a. Soluble Therapeutics https://solublebioscience.com/
CytoBioscience, Inc. has purchased Birmingham, Alabama-based Soluble Therapeutics and will move the company’s operations to its San Antonio location.
Details of the multi-million dollar purchase price were not disclosed.
https://solublebioscience.com/former-german-firm-bringing-more-biotech-business-to-san-antonio/
https://www.businesswire.com/news/home/20161220005098/en/Soluble-Therapeutics-Acquired-CytoBioscience
CytoBioScience has 4 locations:
New Orleans, LA
Birmingham, AL
Cologne, Germany
Einhoven, The Netherlands
I hope everyone has an enjoyable Memorial Day weekend. Stay safe.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.